Publication: Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages
Issued Date
2019-12-01
Resource Type
ISSN
20411723
Other identifier(s)
2-s2.0-85070687044
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nature Communications. Vol.10, No.1 (2019)
Suggested Citation
Adeline C.Y. Chua, Jessica Jie Ying Ong, Benoit Malleret, Rossarin Suwanarusk, Varakorn Kosaisavee, Anne Marie Zeeman, Caitlin A. Cooper, Kevin S.W. Tan, Rou Zhang, Bee Huat Tan, Siti Nurdiana Abas, Andy Yip, Anne Elliot, Chester J. Joyner, Jee Sun Cho, Kate Breyer, Szczepan Baran, Amber Lange, Steven P. Maher, François Nosten, Christophe Bodenreider, Bryan K.S. Yeung, Dominique Mazier, Mary R. Galinski, Nathalie Dereuddre-Bosquet, Roger Le Grand, Clemens H.M. Kocken, Laurent Rénia, Dennis E. Kyle, Thierry T. Diagana, Georges Snounou, Bruce Russell, Pablo Bifani Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages. Nature Communications. Vol.10, No.1 (2019). doi:10.1038/s41467-019-11332-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/50025
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages
Author(s)
Adeline C.Y. Chua
Jessica Jie Ying Ong
Benoit Malleret
Rossarin Suwanarusk
Varakorn Kosaisavee
Anne Marie Zeeman
Caitlin A. Cooper
Kevin S.W. Tan
Rou Zhang
Bee Huat Tan
Siti Nurdiana Abas
Andy Yip
Anne Elliot
Chester J. Joyner
Jee Sun Cho
Kate Breyer
Szczepan Baran
Amber Lange
Steven P. Maher
François Nosten
Christophe Bodenreider
Bryan K.S. Yeung
Dominique Mazier
Mary R. Galinski
Nathalie Dereuddre-Bosquet
Roger Le Grand
Clemens H.M. Kocken
Laurent Rénia
Dennis E. Kyle
Thierry T. Diagana
Georges Snounou
Bruce Russell
Pablo Bifani
Jessica Jie Ying Ong
Benoit Malleret
Rossarin Suwanarusk
Varakorn Kosaisavee
Anne Marie Zeeman
Caitlin A. Cooper
Kevin S.W. Tan
Rou Zhang
Bee Huat Tan
Siti Nurdiana Abas
Andy Yip
Anne Elliot
Chester J. Joyner
Jee Sun Cho
Kate Breyer
Szczepan Baran
Amber Lange
Steven P. Maher
François Nosten
Christophe Bodenreider
Bryan K.S. Yeung
Dominique Mazier
Mary R. Galinski
Nathalie Dereuddre-Bosquet
Roger Le Grand
Clemens H.M. Kocken
Laurent Rénia
Dennis E. Kyle
Thierry T. Diagana
Georges Snounou
Bruce Russell
Pablo Bifani
Other Contributor(s)
A-Star, Singapore Immunology Network
Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes
London School of Hygiene & Tropical Medicine
The University of Georgia
Yong Loo Lin School of Medicine
Novartis Institute for Tropical Diseases Pte. Ltd.
Biomedical Primate Research Centre - Rijswijk
University of Otago
Mahidol University
Nuffield Department of Clinical Medicine
Sorbonne Universite
Emory University
Inserm
Novartis Institutes for BioMedical Research
Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes
London School of Hygiene & Tropical Medicine
The University of Georgia
Yong Loo Lin School of Medicine
Novartis Institute for Tropical Diseases Pte. Ltd.
Biomedical Primate Research Centre - Rijswijk
University of Otago
Mahidol University
Nuffield Department of Clinical Medicine
Sorbonne Universite
Emory University
Inserm
Novartis Institutes for BioMedical Research
Abstract
© 2019, The Author(s). The ability to culture pathogenic organisms substantially enhances the quest for fundamental knowledge and the development of vaccines and drugs. Thus, the elaboration of a protocol for the in vitro cultivation of the erythrocytic stages of Plasmodium falciparum revolutionized research on this important parasite. However, for P. vivax, the most widely distributed and difficult to treat malaria parasite, a strict preference for reticulocytes thwarts efforts to maintain it in vitro. Cultivation of P. cynomolgi, a macaque-infecting species phylogenetically close to P. vivax, was briefly reported in the early 1980s, but not pursued further. Here, we define the conditions under which P. cynomolgi can be adapted to long term in vitro culture to yield parasites that share many of the morphological and phenotypic features of P. vivax. We further validate the potential of this culture system for high-throughput screening to prime and accelerate anti-P. vivax drug discovery efforts.